FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 69 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $121,000 | -2.4% | 24,100 | 0.0% | 0.05% | -34.2% |
Q1 2018 | $124,000 | -14.5% | 24,100 | 0.0% | 0.07% | +19.7% |
Q4 2017 | $145,000 | +8.2% | 24,100 | 0.0% | 0.06% | +56.4% |
Q3 2017 | $134,000 | +19.6% | 24,100 | 0.0% | 0.04% | -11.4% |
Q2 2017 | $112,000 | -47.4% | 24,100 | -44.0% | 0.04% | -30.2% |
Q1 2017 | $213,000 | -86.0% | 43,000 | -68.6% | 0.06% | -88.7% |
Q4 2016 | $1,521,000 | +19.9% | 137,000 | 0.0% | 0.56% | +44.9% |
Q3 2016 | $1,269,000 | +95.8% | 137,000 | +34.3% | 0.38% | +40.0% |
Q2 2016 | $648,000 | -2.6% | 102,000 | 0.0% | 0.28% | -8.9% |
Q1 2016 | $665,000 | -19.6% | 102,000 | 0.0% | 0.30% | -13.5% |
Q4 2015 | $827,000 | +10.6% | 102,000 | 0.0% | 0.35% | -18.3% |
Q3 2015 | $748,000 | – | 102,000 | – | 0.43% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 1,667,377 | $15,440,000 | 9.38% |
GREAT POINT PARTNERS LLC | 2,769,425 | $25,645,000 | 6.54% |
Opaleye Management Inc. | 630,000 | $5,834,000 | 3.05% |
Vivo Capital, LLC | 855,000 | $7,917,000 | 2.47% |
DAFNA Capital Management LLC | 278,067 | $2,575,000 | 1.79% |
RA Capital Management | 1,820,138 | $16,854,000 | 1.74% |
SENZAR ASSET MANAGEMENT, LLC | 523,397 | $4,846,656,000 | 1.25% |
Perceptive Advisors | 1,373,284 | $12,717,000 | 0.82% |
Monashee Investment Management LLC | 225,000 | $2,084,000 | 0.73% |
NEXTHERA CAPITAL LP | 125,000 | $1,158,000 | 0.71% |